Powered by 10kinfo
FARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZ) on Monday reported a loss of $3.4 million in its fiscal first quarter. On a per-share basis, the Farmingdale, New York-based company said it had a loss of 7 cents. Losses, adjusted for non-recurring costs and to account for discontinued operations, came to 5 cents per share. The life sciences and biotechnology company posted revenue of $6.2 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENZ at https://www.zacks.com/ap/ENZFARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZ) on Monday reported a loss of $3.4 million in its fiscal first quarter. On a per-share basis, the Farmingdale, New York-based company said it had a loss of 7 cents. Losses, adjusted for non-recurring costs and to account for discontinued operations, came to 5 cents per share. The life sciences and biotechnology company posted revenue of $6.2 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENZ at https://www.zacks.com/ap/ENZFARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZ) on Monday reported a loss of $3.4 million in its fiscal first quarter.On a per-share basis, the Farmingdale, New York-based company said it had a loss of 7 cents. Losses, adjusted for non-recurring costs and to account for discontinued operations, came to 5 cents per share.The life sciences and biotechnology company posted revenue of $6.2 million in the period._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENZ at https://www.zacks.com/ap/ENZAutomated InsightsZacks stock report on ENZ
The Justice Department is suing to block UnitedHealth Group’s $3.3 billion purchase of Amedisys
U.S. stocks slipped as juice ran out for the torrid “Trump trade” that swept Wall Street following Donald Trump’s presidential victory
AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Natera Inc. (NTRA) on Tuesday reported a loss of $31.6 million in its third quarter. The Austin, Texas-based company said it had a loss of 26 cents per share. The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share. The genetic testing company posted revenue of $439.8 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $361.2 million. Natera expects full-year revenue in the range of $1.61 billion to $1.64 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NTRA at https://www.zacks.com/ap/NTRAAUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Natera Inc. (NTRA) on Tuesday reported a loss of $31.6 million in its third quarter. The Austin, Texas-based company said it had a loss of 26 cents per share. The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share. The genetic testing company posted revenue of $439.8 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $361.2 million. Natera expects full-year revenue in the range of $1.61 billion to $1.64 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NTRA at https://www.zacks.com/ap/NTRAAUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Natera Inc. (NTRA) on Tuesday reported a loss of $31.6 million in its third quarter.The Austin, Texas-based company said it had a loss of 26 cents per share.The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.The genetic testing company posted revenue of $439.8 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $361.2 million.Natera expects full-year revenue in the range of $1.61 billion to $1.64 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NTRA at https://www.zacks.com/ap/NTRAAutomated InsightsZacks stock report on NTRA
NEW YORK (AP) — NEW YORK (AP) — Progyny Inc. (PGNY) on Tuesday reported third-quarter earnings of $10.4 million. On a per-share basis, the New York-based company said it had profit of 11 cents. Earnings, adjusted for stock option expense, came to 40 cents per share. The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 37 cents per share. The provider of fertility and family building benefits posted revenue of $286.6 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $294.8 million. For the current quarter ending in December, Progyny expects its per-share earnings to range from 31 cents to 35 cents. The company said it expects revenue in the range of $266.2 million to $281.2 million for the fiscal fourth quarter. Progyny expects full-year earnings in the range of $1.54 to $1.57 per share, with revenue ranging from $1.14 billion to $1.15 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PGNY at https://www.zacks.com/ap/PGNYNEW YORK (AP) — NEW YORK (AP) — Progyny Inc. (PGNY) on Tuesday reported third-quarter earnings of $10.4 million. On a per-share basis, the New York-based company said it had profit of 11 cents. Earnings, adjusted for stock option expense, came to 40 cents per share. The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 37 cents per share. The provider of fertility and family building benefits posted revenue of $286.6 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $294.8 million. For the current quarter ending in December, Progyny expects its per-share earnings to range from 31 cents to 35 cents. The company said it expects revenue in the range of $266.2 million to $281.2 million for the fiscal fourth quarter. Progyny expects full-year earnings in the range of $1.54 to $1.57 per share, with revenue ranging from $1.14 billion to $1.15 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PGNY at https://www.zacks.com/ap/PGNYNEW YORK (AP) — NEW YORK (AP) — Progyny Inc. (PGNY) on Tuesday reported third-quarter earnings of $10.4 million.On a per-share basis, the New York-based company said it had profit of 11 cents. Earnings, adjusted for stock option expense, came to 40 cents per share.The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 37 cents per share.The provider of fertility and family building benefits posted revenue of $286.6 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $294.8 million.For the current quarter ending in December, Progyny expects its per-share earnings to range from 31 cents to 35 cents.The company said it expects revenue in the range of $266.2 million to $281.2 million for the fiscal fourth quarter.Progyny expects full-year earnings in the range of $1.54 to $1.57 per share, with revenue ranging from $1.14 billion to $1.15 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PGNY at https://www.zacks.com/ap/PGNYAutomated InsightsZacks stock report on PGNY
DALLAS (AP) — DALLAS (AP) — Psychemedics Corp. (PMD) on Tuesday reported a loss of $500,000 in its third quarter. On a per-share basis, the Dallas-based company said it had a loss of 9 cents. The drug testing company posted revenue of $5.2 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PMD at https://www.zacks.com/ap/PMDDALLAS (AP) — DALLAS (AP) — Psychemedics Corp. (PMD) on Tuesday reported a loss of $500,000 in its third quarter. On a per-share basis, the Dallas-based company said it had a loss of 9 cents. The drug testing company posted revenue of $5.2 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PMD at https://www.zacks.com/ap/PMDDALLAS (AP) — DALLAS (AP) — Psychemedics Corp. (PMD) on Tuesday reported a loss of $500,000 in its third quarter.On a per-share basis, the Dallas-based company said it had a loss of 9 cents.The drug testing company posted revenue of $5.2 million in the period._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PMD at https://www.zacks.com/ap/PMDAutomated InsightsZacks stock report on PMD
BRENTWOOD, Tenn. (AP) — BRENTWOOD, Tenn. (AP) — Surgery Partners Inc. (SGRY) on Tuesday reported a loss of $31.7 million in its third quarter. The Brentwood, Tennessee-based company said it had a loss of 25 cents per share. Earnings, adjusted for non-recurring costs and stock option expense, came to 19 cents per share. The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 25 cents per share. The surgical facilities operator posted revenue of $770.4 million in the period, which topped Street forecasts. Five analysts surveyed by Zacks expected $769.1 million. Surgery Partners expects full-year revenue of $3.08 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGRY at https://www.zacks.com/ap/SGRYBRENTWOOD, Tenn. (AP) — BRENTWOOD, Tenn. (AP) — Surgery Partners Inc. (SGRY) on Tuesday reported a loss of $31.7 million in its third quarter. The Brentwood, Tennessee-based company said it had a loss of 25 cents per share. Earnings, adjusted for non-recurring costs and stock option expense, came to 19 cents per share. The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 25 cents per share. The surgical facilities operator posted revenue of $770.4 million in the period, which topped Street forecasts. Five analysts surveyed by Zacks expected $769.1 million. Surgery Partners expects full-year revenue of $3.08 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGRY at https://www.zacks.com/ap/SGRYBRENTWOOD, Tenn. (AP) — BRENTWOOD, Tenn. (AP) — Surgery Partners Inc. (SGRY) on Tuesday reported a loss of $31.7 million in its third quarter.The Brentwood, Tennessee-based company said it had a loss of 25 cents per share. Earnings, adjusted for non-recurring costs and stock option expense, came to 19 cents per share.The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 25 cents per share.The surgical facilities operator posted revenue of $770.4 million in the period, which topped Street forecasts. Five analysts surveyed by Zacks expected $769.1 million.Surgery Partners expects full-year revenue of $3.08 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGRY at https://www.zacks.com/ap/SGRYAutomated InsightsZacks stock report on SGRY
LOS ANGELES (AP) — LOS ANGELES (AP) — RadNet Inc. (RDNT) on Sunday reported third-quarter profit of $3.2 million. On a per-share basis, the Los Angeles-based company said it had profit of 4 cents. Earnings, adjusted for one-time gains and costs, were 18 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 15 cents per share. The operator of medical diagnostic imaging centers posted revenue of $461.1 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $437.3 million. RadNet expects full-year revenue in the range of $1.71 billion to $1.76 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RDNT at https://www.zacks.com/ap/RDNTLOS ANGELES (AP) — LOS ANGELES (AP) — RadNet Inc. (RDNT) on Sunday reported third-quarter profit of $3.2 million. On a per-share basis, the Los Angeles-based company said it had profit of 4 cents. Earnings, adjusted for one-time gains and costs, were 18 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 15 cents per share. The operator of medical diagnostic imaging centers posted revenue of $461.1 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $437.3 million. RadNet expects full-year revenue in the range of $1.71 billion to $1.76 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RDNT at https://www.zacks.com/ap/RDNTLOS ANGELES (AP) — LOS ANGELES (AP) — RadNet Inc. (RDNT) on Sunday reported third-quarter profit of $3.2 million.On a per-share basis, the Los Angeles-based company said it had profit of 4 cents. Earnings, adjusted for one-time gains and costs, were 18 cents per share.The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 15 cents per share.The operator of medical diagnostic imaging centers posted revenue of $461.1 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $437.3 million.RadNet expects full-year revenue in the range of $1.71 billion to $1.76 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RDNT at https://www.zacks.com/ap/RDNTAutomated InsightsZacks stock report on RDNT
BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported third-quarter earnings of $16.9 million. The Baton Rouge, Louisiana-based company said it had net income of 51 cents per share. Earnings, adjusted for non-recurring costs, were $1 per share. The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share. The home health care and hospice services provider posted revenue of $587.7 million in the period, also missing Street forecasts. Seven analysts surveyed by Zacks expected $588.1 million. Amedisys shares have risen roughly 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $97.71, a rise of nearly 6% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMED at https://www.zacks.com/ap/AMEDBATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported third-quarter earnings of $16.9 million. The Baton Rouge, Louisiana-based company said it had net income of 51 cents per share. Earnings, adjusted for non-recurring costs, were $1 per share. The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share. The home health care and hospice services provider posted revenue of $587.7 million in the period, also missing Street forecasts. Seven analysts surveyed by Zacks expected $588.1 million. Amedisys shares have risen roughly 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $97.71, a rise of nearly 6% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMED at https://www.zacks.com/ap/AMEDBATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported third-quarter earnings of $16.9 million.The Baton Rouge, Louisiana-based company said it had net income of 51 cents per share. Earnings, adjusted for non-recurring costs, were $1 per share.The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.The home health care and hospice services provider posted revenue of $587.7 million in the period, also missing Street forecasts. Seven analysts surveyed by Zacks expected $588.1 million.Amedisys shares have risen roughly 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $97.71, a rise of nearly 6% in the last 12 months._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMED at https://www.zacks.com/ap/AMEDAutomated InsightsZacks stock report on AMED
BRENTWOOD, Tenn. (AP) — BRENTWOOD, Tenn. (AP) — Brookdale Senior Living Inc. (BKD) on Wednesday reported a loss of $50.7 million in its third quarter. On a per-share basis, the Brentwood, Tennessee-based company said it had a loss of 22 cents. The senior housing company posted revenue of $784.2 million in the period. Brookdale shares have increased 11% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.46, an increase of 57% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BKD at https://www.zacks.com/ap/BKDBRENTWOOD, Tenn. (AP) — BRENTWOOD, Tenn. (AP) — Brookdale Senior Living Inc. (BKD) on Wednesday reported a loss of $50.7 million in its third quarter. On a per-share basis, the Brentwood, Tennessee-based company said it had a loss of 22 cents. The senior housing company posted revenue of $784.2 million in the period. Brookdale shares have increased 11% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.46, an increase of 57% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BKD at https://www.zacks.com/ap/BKDBRENTWOOD, Tenn. (AP) — BRENTWOOD, Tenn. (AP) — Brookdale Senior Living Inc. (BKD) on Wednesday reported a loss of $50.7 million in its third quarter.On a per-share basis, the Brentwood, Tennessee-based company said it had a loss of 22 cents.The senior housing company posted revenue of $784.2 million in the period.Brookdale shares have increased 11% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.46, an increase of 57% in the last 12 months._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BKD at https://www.zacks.com/ap/BKDAutomated InsightsZacks stock report on BKD